The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials
Cancer Gene Therapy advance online publication, April 14 2017. doi:10.1038/cgt.2017.9
Authors: L Ansari, F Shiehzadeh, Z Taherzadeh, S Nikoofal-Sahlabadi, A A Momtazi-borojeni, A Sahebkar & S Eslami
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2ou8GRb
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου